This activity is consistent with transgenic mice models showing that FOXM1 expression promotes early steps in tumorigenesis, promoting Clara cell and hepatocyte hyperplasia for example [84, 85] and acting in conjunction with many other carcinogens [86] as well as cancer cell lines [87, 88]. This evidence concerns the gene FOXM1 and cancer.